Chronic Metformin Associated Cardioprotection Against Infarction: Not Just a Glucose Lowering Phenomenon
Open Access
- 29 November 2012
- journal article
- Published by Springer Science and Business Media LLC in Cardiovascular Drugs and Therapy
- Vol. 27 (1), 5-16
- https://doi.org/10.1007/s10557-012-6425-x
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injuryAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Metformin Induces Cardioprotection against Ischaemia/Reperfusion Injury in the Rat Heart 24 Hours after AdministrationBasic & Clinical Pharmacology & Toxicology, 2008
- Acute Metformin Therapy Confers Cardioprotection Against Myocardial Infarction Via AMPK-eNOS–Mediated SignalingDiabetes, 2008
- Diabetes and cardiovascular disease: the road to cardioprotectionHeart, 2005
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001
- Mechanism by which metformin reduces glucose production in type 2 diabetes.Diabetes, 2000
- Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chainBiochemical Journal, 2000
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)BMJ, 1998
- Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDMDiabetologia, 1994